文献速递精神分裂症与精神病性障碍心境障碍物质与行为成瘾

重性精神障碍与物质使用障碍的发作次数作为遗传风险与遗传异质性的指标

The number of episodes of major psychiatric and substance use disorders as an index of genetic risk and genetic heterogeneity.
PubMed 文献 · Mol Psychiatry · 2024-09-02

该研究基于瑞典人群登记数据,探讨五种主要障碍(药物使用障碍、酒精使用障碍、重性抑郁、双相障碍、精神分裂症)的发作次数是否反映遗传风险与遗传异质性。利用家族遗传风险评分衍生的遗传风险比发现,五种主要障碍的遗传风险均随发作次数增加而上升,但遗传异质性的变化模式存在病种间差异。

要点

  • 五种主要障碍的遗传风险均随发作次数增加而上升。
  • 酒精使用障碍与药物使用障碍高发作次数者遗传风险更高且遗传信号更纯。
  • 重性抑郁的遗传风险在中等发作次数时达到最大。

核心结论

  • 发作次数是五种主要障碍中遗传风险与遗传异质性的稳健指标,且存在重要的病种间差异。

研究设计与样本

  • 利用瑞典人群登记数据,纳入药物使用障碍、酒精使用障碍、重性抑郁、双相障碍和精神分裂症五种主要障碍,采用家族遗传风险评分衍生的遗传风险比进行分析。

主要发现

  • 五种主要障碍的遗传风险均随发作次数增加而稳健上升。
  • 酒精使用障碍和药物使用障碍中,六种次要障碍的遗传风险比均随发作次数增加而下降,高发作次数者遗传风险更高且遗传信号更纯。
  • 重性抑郁的遗传风险在中等发作次数时达到最大,其酒精使用障碍和药物使用障碍的遗传风险比随发作次数增加而急剧下降,而双相障碍的遗传风险比上升。
  • 双相障碍的遗传风险随发作次数增加而急剧上升,次要障碍的遗传风险比呈增减混合模式,高复发率者整体遗传风险高且遗传信号相对同质。
  • 精神分裂症的遗传风险随发作次数增加而中度上升,其他非情感性精神病和孤独症谱系障碍的遗传风险比下降较慢,高复发率者遗传风险高且信号相对纯。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigate whether number of episodes (NoEs) meaningfully reflect genetic risk and genetic heterogeneity for five primary disorders-Drug Use Disorder (DUD), Alcohol Use Disorder (AUD), Major Depression (MD), Bipolar Disorder (BD), and Schizophrenia (SZ) ascertained from Swedish population registries. We utilize Genetic Risk Ratios (GRR)-defined as the ratio of the genetic risk for secondary disorders to the genetic risk for the primary disorder-derived from Family Genetic Risk Scores (FGRS). For all five primary disorders, genetic risk rose robustly with increasing NoEs. For both AUD and DUD, the GRR for all six secondary disorders-selected to have a likely genetic relationship with the particular primary disorder-declined with increasing NoEs so that cases of AUD and DUD with high versus low NoEs had both a higher genetic risk and a purer genetic signal. With MD, genetic risk maximized at an intermediate NoEs. While the GRRs for AUD and DUD in MD cases dropped sharply with increasing NoEs, GRR for BD increased. For BD, genetic risk rose sharply with increasing NoEs while for all secondary disorders the GRRs showed a mixture of modest increases and decreases. Like AUD and DUD, but even more markedly, selecting BD cases with high rates of recurrence would produce a sample with a high overall genetic risk and a relatively homogeneous genetic signal. For SZ, genetic risk rose moderately with increases in NoEs. GRRs for other non-affective psychoses (ONAP) and autism spectrum disorder (ASD) fell quite slowly with increasing NoEs, and more rapidly for other secondary disorders. Cases of SZ with high recurrence rates had a high genetic risk and a relatively pure signal, albeit with contributions from ONAP and ASD. In summary, NOEs are a robust index of genetic risk and genetic heterogeneity across our primary disorders with important inter-disorder differences.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kendler KS, Ohlsson H, Sundquist J, et al. The number of episodes of major psychiatric and substance use disorders as an index of genetic risk and genetic heterogeneity. Mol Psychiatry. 2024. PMID: 39223278. doi:10.1038/s41380-024-02727-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。